FairValu
AMGEN INC

AMGEN INC

AMGNNasdaqGS
Drug Manufacturers - General • Healthcareamgen.com
Current Price
$385.650.00%
Market Cap
$208.49B
Shares Outstanding: 540.63M
Volume
-
Avg Vol (3M): -
Next Earnings
-
52 Week Range
Low: $--High: $--

Comprehensive AI Analysis

Strategic AI Analysis for AMGN

Checking whether the approved providers contain enough current financial data for a reliable report.

Latest results at a glance

Insights from the latest company results and reports

  • Quarterly Earnings Exceed Consensus

    Reported EPS of $6.29 per share for the quarter ended 2026-06-30 exceeded the same-quarter consensus estimate of $5.62 per share.

  • Revenue Growth Accelerates

    Revenue for the quarter ended 2026-06-30 was $10.05bn, representing a 9.53% increase from $9.18bn in the same quarter of the prior year.

  • Net Income Rises Sharply

    Net income for the quarter ended 2026-06-30 was $2.38bn, up 65.85% from $1.43bn recorded in the quarter ended 2025-06-30.

  • Gross Margin Expands

    Gross margin for the quarter ended 2026-06-30 was 72.04%, wider than the 67.20% recorded for the quarter ended 2025-06-30.

  • EVENITY Segment Grows Rapidly

    EVENITY revenue was $550.0m for the period ended 2026-06-30, up 39.2% from $395.0m in the same period of the prior year.

AI-generated · updated 7 Sept 2026

Company research evidence

Checked financial measurements with the values, reporting periods and measurement basis shown together. This evidence is available independently of the AI report.

Loading evidence…

Deep Dive Research

Source-linked company research for AMGN

Revenue segmentation

Loading segment disclosures…